Overview

Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover study was conducted to compare the relative bioavailability of equal doses of the test and reference products under non-fasted conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Ranbaxy Laboratories Limited
Treatments:
Donepezil